With upfront buy-in from executive leadership in industry, academia and non-profits, Project Data Sphere for cancer could overcome challenges that have slowed other data-sharing efforts.
The cancer data-sharing group Project Data Sphere met with the Critical Path Institute to learn from the institute's data-sharing initiatives for neurodegenerative diseases.
PRODUCT DISCOVERY & DEVELOPMENT
Data reported so far for the most advanced PCSK9 inhibitors look similar, but trials in the LDL-lowering indications where the products will see the earliest uptake are still to come.
EMERGING COMPANY PROFILE
Quantum Biosystems has joined the single-molecule sequencing race with a solid-state system that could offer improved development timelines over nanopore technologies.
Whatever caused Kenneth Moch to depart Chimerix as president and CEO, it wasn't stock performance.
In a Guest Commentary, two capital market veterans argue it is time to modify SEC disclosure rules that are not only a burden to young public biotechs, but do little to actually help investors.
Early backing from strategic investors and a string of deals like a new Celgene partnership have given Forma a free hand to build its drug discovery engine without leaning on VCs.
Deerfield's new crossover mandate. Nucana's B may be plenty. SkyPharma's debt riddance. Spinifex's U.S. beachhead. Also: Gilead; Biogen; Agios; Idenix; Puma; Adamas; Celladon, et al.